NCT00383383View on ClinicalTrials.gov

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

PHASE3CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

December 31, 1999

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Hepatitis B adjuvanted vaccine

BIOLOGICAL

Engerix-B

Trial Locations (3)

Unknown

GSK Clinical Trials Call Center, Hradec

GSK Clinical Trials Call Center, Kuala Lumpur

GSK Clinical Trials Call Center, Málaga

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00383383 - Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years | Biotech Hunter | Biotech Hunter